End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.78 ZAR | -2.50% | -2.50% | 0.00% |
Mar. 29 | Ascendis Health Seeks Acquisitions | CI |
Mar. 28 | Ascendis Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 1.56B 81.59M | Sales 2023 | 1.54B 80.34M | Capitalization | 412M 21.56M |
---|---|---|---|---|---|
Net income 2022 | 449M 23.49M | Net income 2023 | 75M 3.92M | EV / Sales 2022 | 0.48 x |
Net Debt 2022 | 424M 22.2M | Net cash position 2023 | 55.12M 2.88M | EV / Sales 2023 | 0.23 x |
P/E ratio 2022 |
0.73
x | P/E ratio 2023 |
5.31
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.48% |
1 day | -2.50% | ||
1 week | -2.50% | ||
Current month | -3.70% | ||
1 month | -2.50% | ||
3 months | -3.70% | ||
6 months | +11.43% |
Managers | Title | Age | Since |
---|---|---|---|
Carl Neethling
CEO | Chief Executive Officer | - | 22-06-12 |
Joseph Fine
SEC | Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Theunis de Bruyn
BRD | Director/Board Member | 56 | 22-10-18 |
Bharti Harie
CHM | Chairman | 53 | 22-06-12 |
Carl Neethling
CEO | Chief Executive Officer | - | 22-06-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +0.68% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.78 | -2.50% | 66,888 |
24-04-23 | 0.8 | 0.00% | 66,452 |
24-04-22 | 0.8 | 0.00% | 26,990 |
24-04-19 | 0.8 | 0.00% | 7,783 |
24-04-18 | 0.8 | 0.00% | 3,482 |
End-of-day quote Johannesburg S.E., April 23, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 25.4M | |
+25.61% | 660B | |
+24.24% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.45% | 219B | |
-9.65% | 196B | |
+6.52% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- ASC Stock